Abstract
Background: The focus of this study was to prepare and characterize the single-chain variable fragment antibody (scFv)-coupled immunoaffinity column for purification of subtilisin BRC.
Methods: The scFv against subtilisin BRC was immobilized onto CNBr-activated Sepharose 4B. Adsorption isotherm for subtilisin BRC on scFv-BRC-coupled Sepharose 4B was obtained and calculated the maximum binding capacity. The extraction conditions, including eluting solution, the concentration of eluting solution and flow rate, were optimized. Under the optimized eluting conditions, the dynamic binding capacity of the immunoaffinity column was determined.
Results: The scFv-BRC-coupled Sepharose 4B for immunoaffinity purification of subtilisin BRC was prepared. The coupling efficiency was about 78.4%, e.g. about 8 mg of scFv-BRC was covalently coupled to 1 g CNBr-activated Sepharose 4B. The maximum equilibrium binding capacity (qm) and dissociation constant (Kd) of the immunoaffinity column for subtilisin BRC were 3.01 mg/mL and 0.465 mg/mL, respectively. The immunoaffinity chromatography conditions were optimized and the subtilisin BRC was purified 3.29-fold with 55.6%.
Conclusion: The subtilisin BRC was effectively purified with high purity using scFv-BRC-coupled Sepharose 4B and the dynamic binding capacity of the column was determined. These results suggested that scFv-BRC can be used as a ligand for affinity purification of subtilisin BRC.
Keywords: Subtilisin BRC, fibrinolytic enzyme, scFv, immunoaffinity chromatography, dynamic binding capacity, Bacillus subtilis natto-89.
Graphical Abstract
[http://dx.doi.org/10.1016/j.enzmictec.2010.07.004]
[http://dx.doi.org/10.1093/clinchem/48.8.1194] [PMID: 12142372]
[http://dx.doi.org/10.1111/j.1538-7933.2004.00645.x] [PMID: 15102005]
[http://dx.doi.org/10.1016/j.bbagen.2018.11.006]
[http://dx.doi.org/10.1023/A:1026557600429] [PMID: 11195976]
[http://dx.doi.org/10.1080/10826068.2016.1181083] [PMID: 27136080]
[http://dx.doi.org/10.1007/s10811-015-0550-4]
[http://dx.doi.org/10.1007/s10529-006-9284-3] [PMID: 17308884]
[http://dx.doi.org/10.1007/BF01956052] [PMID: 3478223]
[http://dx.doi.org/10.1016/S1096-4959(02)00183-5] [PMID: 12524032]
[http://dx.doi.org/10.1016/S0958-1669(02)00340-3] [PMID: 12323350]
[http://dx.doi.org/10.1016/j.jsps.2015.01.023] [PMID: 26702265]
[http://dx.doi.org/10.1006/prep.2001.1575] [PMID: 11858727]
[http://dx.doi.org/10.1016/j.jbbm.2005.12.007] [PMID: 16503053]
[http://dx.doi.org/10.1016/j.ejca.2004.10.008] [PMID: 15618003]
[http://dx.doi.org/10.1155/2012/980250] [PMID: 22474489]
[http://dx.doi.org/10.2174/2211550108666190417113342]
[http://dx.doi.org/10.1016/B978-0-12-420119-4.00003-3] [PMID: 24674060]
[http://dx.doi.org/10.1016/j.chroma.2019.460629] [PMID: 31668416]
[http://dx.doi.org/10.1016/j.ijbiomac.2019.04.064] [PMID: 30981776]
[http://dx.doi.org/10.1139/W09-057] [PMID: 19898547]
[http://dx.doi.org/10.1038/227680a0] [PMID: 5432063]
[http://dx.doi.org/10.1111/j.1365-2621.1991.tb05360.x]
[http://dx.doi.org/10.1016/S0165-022X(01)00211-1] [PMID: 11694292]
[PMID: 24312807]